Published in Diabetes on July 01, 1976
Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A (1977) 1.94
Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair Regen (2010) 1.12
The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J (2001) 1.04
Streptozocin-induced diabetic mouse model of urinary tract infection. Infect Immun (2008) 1.02
Needs for animal models of human diseases of the endocrine system. Am J Pathol (1980) 0.87
Streptozotocin is equally diabetogenic whether administered to fed or fasted mice. Lab Anim (2013) 0.83
Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics. J Biomed Sci (2013) 0.83
Genes mediating environment interactions in type 1 diabetes. Rev Diabet Stud (2006) 0.82
Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism. Mol Neurobiol (2015) 0.81
Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes. Transl Stroke Res (2016) 0.81
Anti-diabetic activity of different oils through their effect on arylsulfatases. J Diabetes Metab Disord (2014) 0.79
N-3-pyridylmethyl-N'-p-nitrophenylurea ocular toxicity in man and an animal model. Trans Am Ophthalmol Soc (1986) 0.78
Antidiabetic and antioxidant effects of catalpol extracted from Rehmannia glutinosa (Di Huang) on rat diabetes induced by streptozotocin and high-fat, high-sugar feed. Chin Med (2016) 0.75
Enterovirus and type 1 diabetes: What is the matter? World J Diabetes (2015) 0.75
Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms. Eur Neuropsychopharmacol (2014) 0.75
Pesticidal diabetes. Br Med J (1979) 0.75
Spatially resolved changes in diabetic rat skeletal muscle metabolism in vivo studied by 31P-n.m.r. spectroscopy. Biochem J (1990) 0.75
Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats. Korean J Physiol Pharmacol (2016) 0.75
Curcumin protects rat liver from streptozotocin-induced diabetic pathophysiology by counteracting reactive oxygen species and inhibiting the activation of p53 and MAPKs mediated stress response pathways. Toxicol Rep (2015) 0.75
Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science (1976) 4.08
A transplantable insulinoma in the rat. Proc Natl Acad Sci U S A (1977) 3.70
The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes (1977) 2.70
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A (1995) 2.06
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol (2009) 2.00
Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med (1983) 2.00
Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev (2001) 1.96
Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A (1977) 1.94
Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. J Exp Med (1987) 1.93
Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science (1979) 1.87
Immunology of insulin-dependent diabetes mellitus. Annu Rev Immunol (1985) 1.84
The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome. Diabetologia (1978) 1.79
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol (2008) 1.68
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest (1998) 1.67
Ultramicro method for determination of glycogen and glucose by enzymic labeling with adenosine triphosphate-gamma-32P. Anal Biochem (1969) 1.66
The BB rat. Diabetes Metab Rev (1987) 1.65
Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol (2000) 1.64
Adoptive transfer of autoimmune diabetes mellitus in biobreeding/Worcester (BB/W) inbred and hybrid rats. J Immunol (1985) 1.60
Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure. N Engl J Med (1985) 1.57
Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med (1986) 1.57
Embryogenesis of the human pancreatic islets: a light and electron microscopic study. Diabetes (1972) 1.55
Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat. Diabetologia (1987) 1.55
First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med (1985) 1.48
Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science (1982) 1.46
Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature (1978) 1.45
Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol (2000) 1.41
Costimulation and autoimmune diabetes in BB rats. Am J Transplant (2006) 1.41
Monolayer cell culture of neonatal rat pancreas: an ultrastructural and biochemical study of functioning endocrine cells. J Ultrastruct Res (1973) 1.38
Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science (1991) 1.37
Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol (1972) 1.35
Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes (1981) 1.33
Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation (1997) 1.33
Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia (2000) 1.31
The ultrastructure of the secretory cells of the islets of Langerhans in man. Lab Invest (1967) 1.30
Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat. Science (1983) 1.29
Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol (1986) 1.26
Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes (1984) 1.26
Acquired defect in interleukin-2 production in patients with type I diabetes mellitus. N Engl J Med (1986) 1.25
Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol (1986) 1.23
Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes (1981) 1.22
"Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas. N Engl J Med (1977) 1.22
Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Lab Invest (1978) 1.21
Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. Diabetes (1984) 1.20
Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol (1996) 1.20
Pancreatic beta cell toxicity by streptozotocin anomers. Diabetes (1977) 1.20
Diabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic. J Immunol (1986) 1.19
Pathogenesis of macrovascular disease in the human diabetic. Diabetes (1980) 1.18
Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes. Diabetes (1983) 1.17
Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes (1977) 1.16
Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes (1982) 1.15
Genetic analysis of the BB/W diabetic rat. Can J Genet Cytol (1983) 1.14
Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc Natl Acad Sci U S A (1990) 1.14
Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia (1970) 1.13
NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes (1999) 1.12
Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes (1978) 1.12
Autoantibodies in the BB/W rat. Diabetes (1982) 1.09
Studies in the diabetic mutant mouse. II. Electron microscopy of pancreatic islets. Diabetologia (1970) 1.09
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol (1999) 1.08
Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes (1984) 1.08
Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev (1992) 1.08
Autoimmunity after islet-cell allotransplantation. N Engl J Med (2006) 1.08
The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes. Diabetes (1979) 1.07
Animal models of diabetes. Am J Med (1981) 1.07
Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest (1984) 1.07
Insulin and glucagon release from monolayer cell cultures of pancreas from newborn rats. Eur J Clin Invest (1973) 1.07
Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II. Endocrinology (1995) 1.06
Monozygotic triplets with discordance for diabetes mellitus and diabetic microangiopathy. Diabetes (1977) 1.05
Studies in the diabetic mutant mouse. 3. Physiological factors associated with alterations in beta cell proliferation. Diabetologia (1970) 1.05
Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease. J Immunol (1999) 1.04
Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A. Am J Pathol (1984) 1.04
Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes (1991) 1.03
Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes (1979) 1.01
Immune attack on pancreatic islet transplants in the spontaneously diabetic BioBreeding/Worcester (BB/W) rat is not MHC restricted. J Immunol (1985) 1.00
Skin allograft maintenance in a new synchimeric model system of tolerance. J Immunol (2001) 0.99
Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol (1993) 0.99
Spontaneous autoimmune diabetes mellitus in the BioBreeding/Worcester rat. Surv Synth Pathol Res (1984) 0.99
Sex differences in the multiple-dose streptozotocin model of diabetes. Endocrinology (1978) 0.98